$190M deal: Endo buying North Jersey specialty pharma company

Endo International reached a definitive agreement to acquire  Somerset Therapeutics and its affiliated contract manufacturer in India for $190 million. Based in Somerset, N.J., Somerset Therapeutics is a specialty pharmaceutical company that develops and markets sterile injectable products. Its Bangalore, India, affiliate, Wintac Ltd., operates as Somerset Therapeutics' contract developer and manufacturer.  Paul Campanelli, president and CEO of Endo, said the acquisition will expand the product…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news